Healthcare -
Biotechnology - NASDAQ - US
$ 0.188
2.68 %
$ 12.3 M
Market Cap
-0.13
P/E
LYRA - OTHER LONG-TERM ASSETS
Other Long-term Assets LYRA - Lyra Therapeutics, Inc.
2.5 M
LAST VALUE
81.24%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR